Faites connaître cette offre !
Reference : UMR9198-JOAMEN-006
Workplace : GIF SUR YVETTE
Date of publication : Thursday, December 17, 2020
Type of Contract : FTC Technical / Administrative
Contract Period : 13 months
Expected date of employment : 1 October 2021
Proportion of work : Full time
Remuneration : Monthly salary before taxes (brut) from 2510E to 2695E according to the experience level
Desired level of education : Engineer
Experience required : 1 to 4 years
The research engineer will work in a project combining microbiology, biochemsitry, crystallography and small molecule screening, as part of the ATIP-Avenir team MalReg at the Institute for Integrative Biology (I2BC) (UMR9198). The goal of the project is to determine how two essential nuclear proteins from the malaria parasite, Plasmodium falciparum, interact in order to design protein complex inhibitors. This is a collaborative project between MalReg and two other teams, one at the I2BC and one at IPSIT.
- Design and develop as a specialist a project involving biology and biochemistry
- Analyse, discuss and validate the experimental results
- Present the results
- Establish protocols
-Rigor and autonomy
-Proficiency in molecular biology techniques, biochemistry and cell culture
-Ability to work as a team and be a team player
-Assemble experimental results and ability to present his/her work orally and in writing
-Good English skills
The engineer will have the opportunity to participate in the implementation of a new team and will work under the supervision of the lab head in collaboration with the team members, the facilities personnel and the collaborators.
The candidate will work in the « MalReg» team, in the genome biology department of the Institute for Integrative Biology.
This is a DIM1 Health funded position that may be renewed.
The I2BC is a major University of Paris-Saclay/CNRS/CEA research unit situated in the research campus of Gif-sur-Yvette, 35km southwest of Paris. The campus is in close proximity to a natural park and is deserved by public transportation with direct access to Paris. The institute hosts around 700 people among 65 research teams and 13 state-of-the-art technical facilities.
Constraints and risks
Handling of level BSL3* pathogens and red blood cells.
We talk about it on Twitter!